Candriam SCA’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,398
| Closed | -$316K | – | 880 |
|
|
2023
Q1 | $316K | Sell |
4,398
-7,375
| -63% | -$530K | ﹤0.01% | 850 |
|
|
2022
Q4 | $979K | Sell |
11,773
-1,500
| -11% | -$125K | 0.01% | 699 |
|
|
2022
Q3 | $1.22M | Hold |
13,273
| – | – | 0.01% | 674 |
|
|
2022
Q2 | $1.99M | Hold |
13,273
| – | – | 0.02% | 509 |
|
|
2022
Q1 | $3.22M | Hold |
13,273
| – | – | 0.02% | 438 |
|
|
2021
Q4 | $4.01M | Hold |
13,273
| – | – | 0.03% | 401 |
|
|
2021
Q3 | $5.49M | Hold |
13,273
| – | – | 0.04% | 385 |
|
|
2021
Q2 | $4.07M | Sell |
13,273
-15,136
| -53% | -$4.64M | 0.03% | 447 |
|
|
2021
Q1 | $5.46M | Hold |
28,409
| – | – | 0.05% | 355 |
|
|
2020
Q4 | $5.68M | Sell |
28,409
-439
| -2% | -$87.8K | 0.05% | 364 |
|
|
2020
Q3 | $4.78M | Sell |
28,848
-470
| -2% | -$77.8K | 0.04% | 357 |
|
|
2020
Q2 | $7.27M | Buy |
29,318
+10,716
| +58% | +$2.66M | 0.08% | 267 |
|
|
2020
Q1 | $5.27M | Buy |
18,602
+1
| +0% | +$283 | 0.06% | 333 |
|
|
2019
Q4 | $5.39M | Buy |
18,601
+10,351
| +125% | +$3M | 0.06% | 339 |
|
|
2019
Q3 | $2.25M | Buy |
+8,250
| New | +$2.25M | 0.03% | 462 |
|